This message contains images. If you don't see images, click here to view.
Advertise in this news brief.
|
|
| |
Advertisement
How men can protect against cancer
TIME
It's no surprise that being physically fit helps protect against heart disease, but a person's level of fitness might also have a profound effect on cancer outcomes long before a diagnosis. According to a new study in JAMA Oncology, men who were very fit in middle age were 32 percent less likely to die from cancer after being diagnosed after age 65 than men who weren't fit in midlife.
|
|
Share this article:
    |
|
|
Advertisement
Progress in battling advanced ovarian cancer
U.S. News & World Report
An experimental vaccine and a drug already on the market each may help slow down advanced ovarian cancer, two new studies suggest.
In one, of just 31 patients, researchers found that adding the vaccine to standard treatment staved off a recurrence in women who had advanced-stage ovarian cancer.
The other study, involving women with recurrent ovarian cancer, found that administering the drug Avastin after surgery and chemotherapy stalled the cancer's progression, versus surgery and chemo alone.
| Looking for similar articles? Search here, keyword CANCER CARE. |
|
Most women with early-stage breast cancer avoid extensive lymph node removal, showing increasing adherence to scientific evidence that a radical operation is no longer necessary
ACS
A new study of women with early-stage breast cancer finds that surgeons no longer universally remove most of the lymph nodes in the underarm area when a biopsy of the nearby lymph nodes shows cancer — a major change in breast cancer management. The study, which evaluated data from 2.7 million U.S. breast cancer patients, is published as an "article in press" in the Journal of the American College of Surgeons website in advance of print publication later this year.
Advertisement
Register now for the NCDB Workshop and Survey Savvy
The National Cancer Data Base (NCDB) Workshop and Survey Savvy will be held in Chicago June 17-19. The NCDB Workshop, Maximizing NCDB Data to Improve Your Cancer Program, will review the current uses and future updates for the NCDB quality tools. Major NCDB quality tools will be reviewed with a focus on how the data can be used to inform decisions for cancer program administration and by cancer physicians. Learn about the uses for the cancer registry and how patient navigators can use the data.
Survey Savvy provides in-depth review of the information your cancer committee needs to coordinate a high-quality, patient-centered, multidisciplinary cancer program. Developed by Commission on Cancer (CoC) staff and CoC committee leadership, this program addresses your cancer program's most common questions, issues and concerns regarding CoC standards and compliance.
Whether your cancer program is preparing for a re-accreditation survey or looking for clarification on the standards, this program provides increased understanding of standard requirements and implementation. Through lectures, panel presentations and the opportunity to meet and speak with experts, cancer program members will learn how to use the CoC standards as a framework to develop a comprehensive cancer care program that delivers high-quality and patient-centered care. Plan now to attend these meetings.
Advertisement
PRODUCT SHOWCASE
 |
|
Join a passionate network of people dedicated to improving cancer education! The American Association for Cancer Education champions the highest standards for cancer education through evidence-based practices to achieve quality outcomes. Membership is open to anyone engaged in cancer education and training.
See the Membership Benefits of AACE – Join Today!
|
|
Sugar-seeking MRI could be used to detect early-stage cancer
Medical News Today
A new study conducted by researchers at Johns Hopkins Medicine in Baltimore suggests that detecting sugar molecule biomarkers by magnetic resonance imaging may make biopsies more effective.
Help the CoC demonstrate how accreditation makes a difference
ACS
The Commission on Cancer is looking for your help. We are collecting evidence to demonstrate how CoC accreditation has improved patient outcomes and/or that your patients are receiving high quality care and/or that your patients are more satisfied with their cancer care because they are cared for in a Commission on Cancer accredited cancer program. Please send this information to srubin@facs.org.
Advertisement
US Senate working on breast cancer research bill
WBKO-TV
This year, more than 200,000 women will be diagnosed with breast cancer, and it will prove fatal for more than 40,000 women in the United States alone. In fact, breast cancer, according to the National Breast Cancer Foundation, is the second leading cause of death among women in the country.
"Every family in America I think, has been touched by someone who had breast cancer," said Sen. Shelley Moore Capito, R-WV. Capito's family is one that was affected. She lost her mother-in-law to breast cancer. So, she joined a bi-partisan group of Senators to introduce a bill to try to eradicate the disease by 2020.
Special study targeting cancer surveillance in CoC-accredited programs starts April 1
Improving the current approach to surveillance after active treatment for cancer has been identified as a priority area by a number of organizations, including the Institute of Medicine, Patient-Centered Outcomes Research Institute, and DEcIDE Cancer Consortium. The current guidelines do not account for individual risk and are based on limited evidence. To help address this gap, a Commission on Cancer (CoC) Special Study will be launched April 1 to investigate follow-up and recurrence after cancer treatment in hopes of tailoring follow-up based on individual risk.
Participation in this special study is required by all CoC accredited sites to fulfill Standard 5.7 (with the exception of Veterans Affairs, Department of Defense, pediatric facilities, and facilities with a reference date after Jan. 1, 2008). If this is the first you have heard of the study and want to know if your program's participation is required to meet Standard 5.7, please contact PCORIspecialstudy@facs.org.
|
Miss an issue of The Brief? Click here to visit The Brief archive page.
|
Experts back Angelina Jolie Pitt in choices for cancer prevention
The New York Times
Cancer experts said recently that the actress and filmmaker Angelina Jolie Pitt was wise to have had her ovaries and fallopian tubes removed because she carries a genetic mutation, BRCA1, that significantly increases the risk of ovarian cancer, a disease so difficult to detect that it is often found only at an advanced, untreatable stage.
What the Goldilocks gene means for blood-based cancers
Medical Xpress
If there is too little of it, you're at a greater risk for developing a variety of cancers. And new research at the University of Toronto has discovered that, if there's too much, you're also at a greater risk of developing leukemia — and it's harder to treat because you're also more resistant to chemotherapy.
75 cancer programs earn the Outstanding Achievement Award
ACS
The Commission on Cancer (CoC), a Quality Program of the American College of Surgeons, has presented the 2014 Outstanding Achievement Award (OAA) to 75 CoC-accredited cancer programs in the U.S.
Established in 2004, the OAA recognizes cancer programs that demonstrate excellence by earning commendation for all applicable standards and providing quality care to patients with cancer. A program earns the OAA by completing the accreditation survey and receiving a Performance Report that indicates an accreditation award of "Three-Year with Commendation" outlining the commendation ratings for the seven commendation-level standards and no deficiencies.
Experts: Breast cancer 'is not a single disease'
Medical News Today
A new report from a group of leading medical experts in the United States claims breast cancer is not a single disease; it consists of four molecular subtypes, each with different treatment responses and different survival rates. Incidence of these subtypes varies by age, race/ethnicity and many other factors, according to the experts.
NAPBC Workshop — hotel room cut-off tomorrow
Plan to attend Pursing Excellence through NAPBC Accreditation in Denver (Westminster) on April 24. Faculty will provide the information you need to develop and operate a high-quality breast center. Don't miss this opportunity to meet and interact with this expert faculty that includes Scott. H. Kurtzman, MD, FACS, Colette Salm-Schmid, MD, FACS, Randy Stevens, MD and Colleen Johnson, RN, CBPN-IC.
Register today and make sure to reserve your room at the Westin Westminster Hotel online or by phone 1-888-627-8448 by April 2 to receive the special $159 a night rate.
Missed last week's issue? See which articles your colleagues read most.
|
|
|
Advertisement
|
|
|
The Brief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit
Ashley Whipple, Senior Content Editor, 469.420.2642
Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The CoC and NAPBC do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons, the CoC and the NAPBC.
Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.
This edition of The Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
|
|
Recent issues
March 25, 2015
March 18, 2015
March 11, 2015
Feb. 25, 2015
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
